Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia

被引：0
|
作者：
Clara Pérez-Rambla
Leonor Puchades-Carrasco
María García-Flores
José Rubio-Briones
José Antonio López-Guerrero
Antonio Pineda-Lucena
机构：
[1] Centro de Investigación Príncipe Felipe,Structural Biochemistry Laboratory
[2] Fundación Instituto Valenciano de Oncología,Laboratory of Molecular Biology
[3] Fundación Instituto Valenciano de Oncología,Department of Urology
[4] Instituto de Investigación Sanitaria La Fe,Drug Discovery Unit
来源：
Metabolomics | 2017年 / 13卷
关键词：
Biomarkers; Metabolomics; Prostate cancer; Benign prostatic hyperplasia; Nuclear magnetic resonance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Non-invasive urinary metabolomic profiling discriminates prostate cancer from benign prostatic hyperplasia
    Perez-Rambla, Clara
    Puchades-Carrasco, Leonor
    Garcia-Flores, Maria
    Rubio-Briones, Jose
    Antonio Lopez-Guerrero, Jose
    Pineda-Lucena, Antonio
    METABOLOMICS, 2017, 13 (05)
  • [2] Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone
    Xu, Bei
    Chen, Yan
    Chen, Xi
    Gan, Lingling
    Zhang, Yamei
    Feng, Jiafu
    Yu, Lin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Urinary microbiota in patients with prostate cancer and benign prostatic hyperplasia
    Yu, Haining
    Meng, Hongzhou
    Zhou, Feng
    Ni, Xiaofeng
    Shen, Shengrong
    Das, Undurti N.
    ARCHIVES OF MEDICAL SCIENCE, 2015, 11 (02) : 385 - 394
  • [4] Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer
    Jedinak, Andrej
    Curatolo, Adam
    Zurakowski, David
    Dillon, Simon
    Bhasin, Manoj K.
    Libermann, Towia A.
    Roy, Roopali
    Sachdev, Monisha
    Loughlin, Kevin R.
    Moses, Marsha A.
    BMC CANCER, 2015, 15
  • [5] Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer
    Andrej Jedinak
    Adam Curatolo
    David Zurakowski
    Simon Dillon
    Manoj K Bhasin
    Towia A Libermann
    Roopali Roy
    Monisha Sachdev
    Kevin R Loughlin
    Marsha A Moses
    BMC Cancer, 15
  • [6] Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review
    McNally, Christopher J.
    Ruddock, Mark W.
    Moore, Tara
    McKenna, Declan J.
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5225 - 5241
  • [7] Acute urinary tract infection in patients with underlying benign prostatic hyperplasia and prostate cancer
    Tolani, Musliu Adetola
    Suleiman, Aisha
    Awaisu, Mudi
    Abdulaziz, Muhammad Mukhtar
    Lawal, Ahmad Tijjani
    Bello, Ahmad
    PAN AFRICAN MEDICAL JOURNAL, 2020, 36 : 1 - 9
  • [8] Osteopontin expression in prostate cancer and benign prostatic hyperplasia
    Tozawa, K
    Yamada, Y
    Kawai, N
    Okamura, T
    Ueda, K
    Kohri, K
    UROLOGIA INTERNATIONALIS, 1999, 62 (03) : 155 - 158
  • [9] Hounsfield units: A promising non-invasive tool for diagnosing benign prostatic hyperplasia
    Yilmaz, O.
    Hayit, H.
    Yesildal, C.
    Yenigurbuz, S.
    Yilmaz, F.
    Kizilkan, Y. Emre
    ACTAS UROLOGICAS ESPANOLAS, 2022, 46 (07): : 407 - 412
  • [10] Oxidative Stress in Benign Prostatic Hyperplasia and Prostate Cancer
    Pace, Gianna
    Di Massimo, Caterina
    De Amicis, Daniela
    Corbacelli, Carlo
    Di Renzo, Laura
    Vicentini, Carlo
    Miano, Lucio
    Ciancarelli, Maria Giuliana Tozzi
    UROLOGIA INTERNATIONALIS, 2010, 85 (03) : 328 - 333
12345